🇺🇸
United States · US · US:59310-610_a509df2c-67b6-40c3-8b6d-f9de54b62c8a
CINQAIR
UNIISPLATC R03DX08
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerTeva Respiratory, LLC
CountryUS (United States)
ATC codeR03DX08
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc1159310610311 VIAL, SINGLE-USE in 1 CARTON (59310-610-31) / 10 mL in 1 VIAL, SINGLE-USE
Annotations
UNII (FDA Substance ID)
35A26E427H
RESLIZUMAB
RxCUI 1746889
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "35A26E427H",
"rxcui": "1746889",
"inchikey": null,
"display_name": "RESLIZUMAB",
"substance_type": "protein",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "INTRAVENOUS",
"spl_meta": {
"053b9158-2a5b-48b9-bf47-5fa78a35ec33": {
"match": "brand_token",
"title": "CINQAIR (RESLIZUMAB) INJECTION, SOLUTION, CONCENTRATE [TEVA RESPIRATORY, LLC]",
"spl_version": "14",
"published_date": "2026-05-15"
}
},
"productid": "59310-610_a509df2c-67b6-40c3-8b6d-f9de54b62c8a",
"productndc": "59310-610",
"dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "RESLIZUMAB",
"proprietary_name": "CINQAIR",
"active_ingred_unit": "mg/mL",
"application_number": "BLA761033",
"marketing_category": "BLA",
"nonproprietary_name": "Reslizumab",
"start_marketing_date": "20160418",
"active_numerator_strength": "10"
}Related drugs
Other records sharing ATC code R03DX08.
Access this data programmatically
Query CINQAIR and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.